Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Adu-Afarwuah S et al. |
Maternal and Infant Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Increases Infants' Iron Status at 18 Months of Age in a Semiurban Setting in Ghana: A Secondary Outcome Analysis of the iLiNS-DYAD Randomized Controlled Trial.
|
2 |
Aho H. |
Social Involvement and Adolescent Smoking : Associations and Students’ Views of Smoking in a Vocational School Setting.
|
3 |
Aho H et al. |
The relationship between peer relations, self-rated health and smoking behaviour in secondary vocational schools.
|
4 |
Aho H et al. |
Practical nursing students' discursive practices on smoking in Finland.
|
5 |
Andrén Aronsson C et al. |
Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.
|
6 |
Archer M et al. |
Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers.
|
7 |
Archer M et al. |
Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder.
|
8 |
Aula H et al. |
Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer.
|
9 |
Bannuru RR et al. |
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.
|
10 |
Bläuer M et al. |
Wnt/ß-catenin signalling plays diverse functions during the process of fibrotic remodelling in the exocrine pancreas.
|
11 |
Booth N et al. |
Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.
|
12 |
Choudhary MK et al. |
Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects.
|
13 |
Elia N et al. |
Myasthenic congenital myopathy from recessive mutations at a single residue in NaV1.4.
|
14 |
Ellonen N et al. |
The use of the Brief Child Abuse Potential Inventory in the general population in Finland.
|
15 |
Endesfelder D et al. |
Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children.
|
16 |
Fiorito G et al. |
Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis.
|
17 |
Galdikiene N et al. |
The association of primary healthcare nurses’ perceived stress with organizational culture and climate in a team context .
|
18 |
Gering C et al. |
Design of modular gellan gum hydrogel functionalized with avidin and biotinylated adhesive ligands for cell culture applications.
|
19 |
González de Cózar JM et al. |
RNase H1 promotes replication fork progression through oppositely transcribed regions of .
|
20 |
Hackman G et al. |
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
|
21 |
Hallamaa L et al. |
The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine-pyrimethamine on child weight, mid-upper arm circumference and head circumference: A randomized controlled trial.
|
22 |
Hammarén H et al. |
The regulation of JAKs in cytokine signaling and its breakdown in disease.
|
23 |
Hautalahti J et al. |
Vibration transmittance measures sternotomy stability - a preliminary study in human cadavers.
|
24 |
Helminen H et al. |
Predictive value of the mini-nutritional assessment short form (MNA-SF) and nutritional risk screening (NRS2002) in hip fracture.
|
25 |
Hippich M et al. |
Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families.
|
26 |
Hokkila E et al. |
The efficacy of misoprostol vaginal insert compared with oral misoprostol in the induction of labor of nulliparous women: A randomized national multicenter trial.
|
27 |
Hongisto MT et al. |
Delay to Surgery of Less Than 12 Hours Is Associated With Improved Short- and Long-Term Survival in Moderate- to High-Risk Hip Fracture Patients.
|
28 |
Hopia H, Heino-Tolonen T. |
Families in Paediatric Oncology Nursing: Critical Incidents From the Nurses' Perspective.
|
29 |
Huttala O et al. |
Presence of vasculature results in faster insulin response in adipocytes in vascularized adipose tissue model.
|
30 |
Huuskonen C et al. |
Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload.
|
31 |
Hämäläinen M, Moilanen E. |
Sytokiinit ja sytokiiniverkosto.
|
32 |
Hämäläinen M, Moilanen E. |
Tuumorinekroositekijä.
|
33 |
Hämäläinen M, Moilanen E. |
Interleukiini-1.
|
34 |
Hämäläinen M, Moilanen E. |
Interleukiini-2.
|
35 |
Hämäläinen M, Moilanen E. |
Interleukiini-4.
|
36 |
Hämäläinen M, Moilanen E. |
Interleukiini-5.
|
37 |
Hämäläinen M, Moilanen E. |
Interleukiini-6.
|
38 |
Hämäläinen M, Moilanen E. |
Interleukiini-12.
|
39 |
Hämäläinen M, Moilanen E. |
Interleukiini-17.
|
40 |
Hämäläinen M, Moilanen E. |
Interleukiini-23.
|
41 |
Hämäläinen M, Moilanen E. |
Tyypin I interferonit.
|
42 |
Hämäläinen M, Moilanen E. |
Interferoni -Y.
|
43 |
Hämäläinen M, Moilanen E. |
Hematopoieettiset kasvutekijät.
|
44 |
Ilmarinen P et al. |
YKL-40 and adult-onset asthma: Elevated levels in clusters with poorest outcome.
|
45 |
Irmola T et al. |
Functional outcome of total knee replacement: a study protocol for a prospective, double-blinded, parallel-group randomized, clinical controlled trial of novel, personalized and conventional implants.
|
46 |
Jacobsen LM et al. |
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
|
47 |
Johnson R et al. |
Metabolite-related dietary patterns and the development of islet autoimmunity.
|
48 |
Kares S et al. |
HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
|
49 |
Karjalainen J et al. |
New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults.
|
50 |
Keiski P et al. |
Female-perpetrated family violence-Effectiveness of a psychodynamic group intervention.
|
51 |
Keränen T. |
The MAP Kinase / MAP Kinase Phosphatase-1 Pathway in the Anti-Inflammatory Effects of ß2 -Agonists and Dexamethasone.
|
52 |
Kiiskinen J et al. |
Nanofibrillar cellulose wound dressing supports the growth and characteristics of human mesenchymal stem/stromal cells without cell adhesion coatings.
|
53 |
Kivelä S et al. |
Continuation of domestic violence and changes in the assessment of family functioning, health, and social support in Finland.
|
54 |
Kivistö JE et al. |
Genetic and environmental susceptibility to food allergy in a registry of twins.
|
55 |
Koivusalo L et al. |
Tissue adhesive hyaluronic acid hydrogels for sutureless stem cell delivery and regeneration of corneal epithelium and stroma.
|
56 |
Korhonen N et al. |
Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006-2015.
|
57 |
Kortekangas E et al. |
A Prospective Study on Child Morbidity and Gut Microbiota in Rural Malawi.
|
58 |
Krischer JP et al. |
Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
|
59 |
Laavola M et al. |
IL-6 in Osteoarthritis: Effects of Pine Stilbenoids.
|
60 |
Lampinen M. |
Yhteisöllisyys sosiaali- ja terveystoimen esimiesyhteisössä.
|
61 |
Lehtimäki L, Moilanen E. |
Hengityselimistö ja sen tehtävät.
|
62 |
Lehtimäki L, Moilanen E. |
Hengityksen säätelyyn vaikuttavat lääkeaineet.
|
63 |
Lehtimäki L, Moilanen E. |
Astma ja keuhkoahtaumatauti.
|
64 |
Lehtimäki L, Moilanen E. |
Astman ja keuhkoahtaumataudin lääkehoidon yleiset periaatteet.
|
65 |
Lehtimäki L, Moilanen E. |
Inhalaatiolääkitys.
|
66 |
Lehtimäki L, Moilanen E. |
Hengitettävät glukokortikoidit.
|
67 |
Lehtimäki L, Moilanen E. |
Leukotrieenien estäjät.
|
68 |
Lehtimäki L, Moilanen E. |
IgE:n estäjät.
|
69 |
Lehtimäki L, Moilanen E. |
Interleukiini-5:n estäjät.
|
70 |
Lehtimäki L, Moilanen E. |
Teofylliini.
|
71 |
Lehtimäki L, Moilanen E. |
Fosfodiesteraasi-4:n estäjät.
|
72 |
Lehtimäki L, Moilanen E. |
Keuhkoputkien sileän lihaksen toiminta.
|
73 |
Lehtimäki L, Moilanen E. |
Keuhkoputkia laajentavat ß2-sympatomimeetit.
|
74 |
Lehtimäki L, Moilanen E. |
Antikolinergiset keuhkoputkia laajentavat lääkeaineet.
|
75 |
Lehtimäki L, Moilanen E. |
Pirfenidoni.
|
76 |
Lehtimäki L, Moilanen E. |
Nintedanibi.
|
77 |
Lehtimäki L, Moilanen E. |
Yskä ja yskänlääkkeet.
|
78 |
Lehtimäki L, Moilanen E. |
Opioidit yskänlääkkeenä.
|
79 |
Lehtimäki L, Moilanen E. |
Mukolyytit.
|
80 |
Lehtimäki L, Moilanen E. |
Hengitystieallergiat ja niiden hoitoperiaatteet.
|
81 |
Lehtimäki L, Moilanen E. |
Antihistamiinit.
|
82 |
Lehtimäki L, Moilanen E. |
Natriumkromoglikaatti ja nedokromiili.
|
83 |
Lehtimäki L, Moilanen E. |
Siedätyshoito allergeeneillä.
|
84 |
Lehtipuro S et al. |
Modes of immunosuppression in glioblastoma microenvironment.
|
85 |
Leppäkoski T et al. |
How Training Impacts the Identification and Discussion of the Risks of Child Maltreatment: A Finnish Follow-Up Study.
|
86 |
Leppänen T, Moilanen E. |
Histamiini.
|
87 |
Leppänen T, Moilanen E. |
Histamiinin biosynteesi, vapautuminen ja hajoaminen.
|
88 |
Leppänen T, Moilanen E. |
Histamiinin vaikutusmekanismi.
|
89 |
Leppänen T, Moilanen E. |
Histamiinin terapeuttinen merkitys.
|
90 |
Leppänen T, Moilanen E. |
Glukokortikoidit.
|
91 |
Leppänen T, Moilanen E. |
Glukokortikoidien vaikutusmekanismi ja vaikutukset.
|
92 |
Leppänen T, Moilanen E. |
Glukokortikoidien haittavaikutukset.
|
93 |
Leppänen T, Moilanen E. |
Histamiinin vaikutukset.
|
94 |
Lietzén N et al. |
Coxsackievirus B Persistence Modifies the Proteome and the Secretome of Pancreatic Ductal Cells.
|
95 |
Luhtala S. |
Novel Biomarkers in HER2-amplified Breast Cancer : Histopathological and Clinical Associations.
|
96 |
Mendelian Randomization of Dairy Consumption Working Group Charge Consortium et al. |
Dairy Intake and Body Composition and Cardiometabolic Traits among Adults: Mendelian Randomization Analysis of 182041 Individuals from 18 Studies.
|
97 |
Mishra A et al. |
In-vitro dissolution characteristics and human adipose stem cell response to novel borophosphate glasses.
|
98 |
Moilanen E. |
Paikalliset välittäjäaineet.
|
99 |
Moilanen E. |
Typpioksidi.
|
100 |
Moilanen E. |
Typpioksidin biosynteesi ja hajoaminen .
|
101 |
Moilanen E. |
Typpioksidin vaikutusmekanismi.
|
102 |
Moilanen E. |
Typpioksidin terapeuttinen merkitys.
|
103 |
Moilanen E. |
Tulehdusreaktio.
|
104 |
Moilanen E. |
Luonnollinen immuunivaste.
|
105 |
Moilanen E. |
Hankittu immuunivaste.
|
106 |
Moilanen E, Nieminen R. |
Eikosanoidit: prostanoidit ja leukotrieenit.
|
107 |
Moilanen E, Nieminen R. |
Prostanoidien biosynteesi ja hajoaminen .
|
108 |
Moilanen E, Nieminen R. |
Prostanoidien vaikutusmekanismi.
|
109 |
Moilanen E, Nieminen R. |
Prostanoidien vaikutukset.
|
110 |
Moilanen E, Nieminen R. |
Prostanoidien terapeuttinen merkitys.
|
111 |
Moilanen E, Nieminen R. |
Leukotrieenien biosynteesi ja hajoaminen.
|
112 |
Moilanen E, Nieminen R. |
Leukotrieenien vaikutusmekanismi ja vaikutukset.
|
113 |
Moilanen E, Nieminen R. |
Leukotrieenien terapeuttinen merkitys.
|
114 |
Moilanen E, Vuolteenaho K. |
Bradykiniinin vaikutusmekanismi ja vaikutukset.
|
115 |
Moilanen L et al. |
Transient Receptor Potential Ankyrin 1 Enhances Ovalbumin-Induced Acute Allergic Inflammation in Murine Models.
|
116 |
Mu J et al. |
Combined Adipose Tissue-Derived Mesenchymal Stem Cell Therapy and Rehabilitation in Experimental Stroke.
|
117 |
Mäkelä K et al. |
Oral versus patient-controlled intravenous administration of oxycodone for pain relief after cesarean section.
|
118 |
Mäki-Opas I et al. |
Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.
|
119 |
Nevalainen T et al. |
CD27- IgD- B cell memory subset associates with inflammation and frailty in elderly individuals but only in males.
|
120 |
Niemi P et al. |
Association between snoring and deciduous dental development and soft tissue profile in 3-year-old children.
|
121 |
Nieminen R, Moilanen E. |
Kihti ja sen lääkehoidon periaatteet.
|
122 |
Nieminen R, Moilanen E. |
Ksantiinioksidaasin estäjät .
|
123 |
Nieminen R, Moilanen E. |
Urikaasit.
|
124 |
Niskanen I et al. |
Effect of Maxillomandibular Advancement Surgery on Pharyngeal Airway Volume and Polysomnography Data in Obstructive Sleep Apnea Patients.
|
125 |
Nkhoma M et al. |
Lipid based nutrient supplements during pregnancy may improve foetal growth in HIV infected women - A cohort study.
|
126 |
Nordback P. |
Natural and synthetic biomaterials for epithelial repair : Skin and urethral regeneration.
|
127 |
Nordic Burden of Disease Collaborators et al. |
Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.
|
128 |
Nuotio M et al. |
Elevated post-void residual volume in a geriatric post-hip fracture assessment in women-associated factors and risk of mortality.
|
129 |
Núñez-Toldrà R et al. |
S53P4 Bioactive Glass Inorganic Ions for Vascularized Bone Tissue Engineering by Dental Pulp Pluripotent-Like Stem Cell Cocultures.
|
130 |
Ojansivu M et al. |
Wood-based nanocellulose and bioactive glass modified gelatin-alginate bioinks for 3D bioprinting of bone cells.
|
131 |
Outinen TK et al. |
Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection.
|
132 |
Ovaskainen K et al. |
Planned home deliveries in Finland, 1996-2013.
|
133 |
Pakarinen M et al. |
Vocational school students' self-evaluations of a sexual health promotion intervention.
|
134 |
Palve J et al. |
A second expert pathology review of cutaneous melanoma in multidisciplinary meetings: Impact on treatment decisions.
|
135 |
palve et al. |
Predictors of Metastasis and Outcome Following True Negative Sentinel Node Biopsy.
|
136 |
Pasternack C et al. |
Risk of fractures in dermatitis herpetiformis and coeliac disease: a register-based study.
|
137 |
Patrakka O et al. |
Oral Bacterial Signatures in Cerebral Thrombi of Patients With Acute Ischemic Stroke Treated With Thrombectomy.
|
138 |
Patrikoski M et al. |
Perspectives for Clinical Translation of Adipose Stromal/Stem Cells.
|
139 |
Paunonen J et al. |
Temporomandibular disorders in Class II malocclusion patients after surgical mandibular advancement treatment as compared to non-treated patients.
|
140 |
Pemmari A et al. |
MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids.
|
141 |
Pyykkö J et al. |
Cross-cultural analysis of attention disengagement times supports the dissociation of faces and patterns in the infant brain.
|
142 |
Pyykkö J et al. |
Early development of visual attention in infants in rural Malawi.
|
143 |
Pyysalo MJ et al. |
Increased tooth brushing frequency is associated with reduced gingival pocket bacterial diversity in patients with intracranial aneurysms.
|
144 |
Rimpilä V. |
Transcutaneous carbon dioxide in sleep-disordered breathing.
|
145 |
Roth R et al. |
The association between stressful life events and respiratory infections during the first 4 years of life: The Environmental Determinants of Diabetes in the Young study.
|
146 |
Ruskoaho H et al., toim. |
Lääketieteellinen farmakologia ja toksikologia, 5 uud. p.
|
147 |
Rönkkö H et al. |
Protective distal side-to-side neurorrhaphy in proximal nerve injury-an experimental study with rats.
|
148 |
Saari S et al. |
Alternative respiratory chain enzymes: Therapeutic potential and possible pitfalls.
|
149 |
Saari S et al. |
Alternative oxidase confers nutritional limitation on Drosophila development.
|
150 |
Salo HM et al. |
No evidence of the role of early chemical exposure in the development of -cell autoimmunity.
|
151 |
Savioja H. |
Sexual behavior in adolescence: The role of depression, delinquency, and family-related factors.
|
152 |
Seppänen P et al. |
Obstetric patients' health-related quality of life before and after intensive care.
|
153 |
Silbernagel G et al. |
LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.
|
154 |
Silvis K et al. |
Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study.
|
155 |
Skyttä T et al. |
Adjuvant radiotherapy-induced cardiac changes among patients with early breast cancer: a three-year follow-up study.
|
156 |
Stanfill B et al. |
Extending Classification Algorithms to Case-Control Studies.
|
157 |
Tabassum R et al. |
Genetic architecture of human plasma lipidome and its link to cardiovascular disease.
|
158 |
Talvitie T et al. |
Adherence to instructions and fluctuation of force magnitude in cervical headgear therapy.
|
159 |
Talvitie TH et al. |
Impact of force magnitude on effectiveness in cervical headgear therapy: a cephalometric analysis.
|
160 |
Tiainen L et al. |
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
|
161 |
Tiainen L et al. |
High baseline Tie1 level predicts poor survival in metastatic breast cancer.
|
162 |
Tolvanen E et al. |
Comparison of the Patient Enablement Instrument (PEI) with two single-item measures among Finnish Health care centre patients.
|
163 |
Trus M. |
Nurse managers' work-related empowerment : Evaluated in connection to power issues and Organizational Social Context.
|
164 |
Trus M et al. |
Connection between organizational culture and climate and empowerment: The perspective of nurse managers.
|
165 |
Tuomisto S et al. |
Age-dependent association of gut bacteria with coronary atherosclerosis: Tampere Sudden Death Study.
|
166 |
Tuure L et al. |
Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1).
|
167 |
Uusitalo U et al. |
Early Probiotic Supplementation and the Risk of Celiac Disease in Children at Genetic Risk.
|
168 |
Vatanen T et al. |
Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life.
|
169 |
Vehik K et al. |
Prospective virome analyses in young children at increased genetic risk for type 1 diabetes.
|
170 |
Veijalainen O et al. |
Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
|
171 |
Vuolteenaho K, Moilanen E. |
Bradykiniini.
|
172 |
Vuolteenaho K, Moilanen E. |
Bradykiniinin biosynteesi ja hajoaminen.
|
173 |
Vuolteenaho K, Moilanen E. |
Bradykiniinin terapeuttinen merkitys.
|
174 |
Vuolteenaho K, Moilanen E. |
Tulehduskipulääkkeiden yleiset ominaisuudet.
|
175 |
Vuolteenaho K, Moilanen E. |
Tulehduskipulääkkeiden vaikutusmekanismi.
|
176 |
Vuolteenaho K, Moilanen E. |
Tulehduskipulääkkeiden vaikutukset.
|
177 |
Vuolteenaho K, Moilanen E. |
Tulehduskipulääkkeiden haittavaikutukset.
|
178 |
Vuolteenaho K, Moilanen E. |
Tulehduskipulääkkeiden kliininen käyttö.
|
179 |
Vuolteenaho K, Moilanen E. |
Propionihappojohdokset.
|
180 |
Vuolteenaho K, Moilanen E. |
Etikkahappojohdokset.
|
181 |
Vuolteenaho K, Moilanen E. |
Oksikaamit.
|
182 |
Vuolteenaho K, Moilanen E. |
Fenamaatit.
|
183 |
Vuolteenaho K, Moilanen E. |
Nabumetoni.
|
184 |
Vuolteenaho K, Moilanen E. |
Koksibit.
|
185 |
Vuolteenaho K, Moilanen E. |
Salisylaatit.
|
186 |
Vuolteenaho K, Moilanen E. |
Parasetamoli.
|
187 |
Vuolteenaho K, Moilanen E. |
Reumalääkkeet ja niiden käyttöperiaatteet.
|
188 |
Vuolteenaho K, Moilanen E. |
Metotreksaatti.
|
189 |
Vuolteenaho K, Moilanen E. |
Sulfasalatsiini.
|
190 |
Vuolteenaho K, Moilanen E. |
Klorokiinijohdokset.
|
191 |
Vuolteenaho K, Moilanen E. |
Penisillamiini.
|
192 |
Vuolteenaho K, Moilanen E. |
Kultayhdisteet.
|
193 |
Vuolteenaho K, Moilanen E. |
Leflunomidi.
|
194 |
Vuolteenaho K, Moilanen E. |
Solunsalpaajat tulehduksellisten reumasairauksien hoidossa.
|
195 |
Vuolteenaho K, Moilanen E. |
Janus-kinaasien estäjät.
|
196 |
Vuolteenaho K, Moilanen E. |
Fosfodiesteraasiestäjät.
|
197 |
Vuolteenaho K, Moilanen E. |
Tuumorinekroositekijän estäjät.
|
198 |
Vuolteenaho K, Moilanen E. |
Interleukiini-1:n estäjät.
|
199 |
Vuolteenaho K, Moilanen E. |
Interleukiini-6:n estäjät.
|
200 |
Vuolteenaho K, Moilanen E. |
Interleukiini-17:n estäjät.
|
201 |
Vuolteenaho K, Moilanen E. |
BLyS-sytokiinin estäjät.
|
202 |
Vuolteenaho K, Moilanen E. |
T-solujen estäjät.
|
203 |
Vuolteenaho K, Moilanen E. |
B-solujen estäjät.
|
204 |
Vuolteenaho K, Moilanen E. |
Immunosuppressiiviset lääkkeet.
|
205 |
Vuolteenaho K, Moilanen E. |
Sirolimuusi.
|
206 |
Vuolteenaho K, Moilanen E. |
Mykofenolaatti.
|
207 |
Vuolteenaho K, Moilanen E. |
Nivelrikko ja sen lääkehoidon periaatteet.
|
208 |
Vuolteenaho K, Moilanen E. |
Glukosamiini ja kondroitiinisulfaatti .
|
209 |
Vuolteenaho K, Moilanen E. |
Hyaluronaatti.
|
210 |
Vuolteenaho K, Moilanen E. |
Nivelrikon hoitoon kehitteillä olevat lääkkeet.
|
211 |
Vuolteenaho K, Moilanen E. |
Kalsineuriinin estäjät.
|
212 |
Vuornos K et al. |
Bioactive glass ions induce efficient osteogenic differentiation of human adipose stem cells encapsulated in gellan gum and collagen type I hydrogels.
|